問卷

TPIDB > Search Result > Clinical Trials List

Clinical Trials List

Protocol NumberD7551C00001
NCT Number(ClinicalTrials.gov Identfier)-

2021-01-22 - 2023-03-23

Phase II

Not yet recruiting2

Recruiting8

-

  • Trial Applicant

    PAREXEL INTERNATIONAL CO., LTD.

  • Sponsor

    -

  • Trial scale

    Multi-Regional Multi-Center

  • Update

    2026/09/23

Investigators and Locations

Principal Investigator Der-Cherng Tarng Division of General Internal Medicine

Co-Principal Investigator

  • 楊智宇 Division of General Internal Medicine
  • 歐朔銘 Division of General Internal Medicine

The Actual Total Number of Participants Enrolled

0 Not yet recruiting

Principal Investigator Ming-Ju Wu Division of General Internal Medicine

Co-Principal Investigator

The Actual Total Number of Participants Enrolled

0 Not yet recruiting

Principal Investigator 王家良 Division of Nephrology

Co-Principal Investigator

The Actual Total Number of Participants Enrolled

0 Recruiting

Principal Investigator 夏德霖 Division of Endocrinology

Co-Principal Investigator

The Actual Total Number of Participants Enrolled

0 Recruiting

Principal Investigator Yuh-Mou Sue Division of Nephrology

Co-Principal Investigator

The Actual Total Number of Participants Enrolled

0 Recruiting

Principal Investigator Ping-Chin Lai Division of Nephrology

Co-Principal Investigator

The Actual Total Number of Participants Enrolled

0 Recruiting

Principal Investigator Jin-Bor Chen Division of Nephrology

Co-Principal Investigator

The Actual Total Number of Participants Enrolled

0 Recruiting

Principal Investigator 洪士元 Division of Nephrology

Co-Principal Investigator

The Actual Total Number of Participants Enrolled

0 Recruiting

Principal Investigator I-WEN WU Division of Nephrology

Co-Principal Investigator

The Actual Total Number of Participants Enrolled

0 Recruiting

Principal Investigator VIN-CENT Wu

Co-Principal Investigator

The Actual Total Number of Participants Enrolled

0 Recruiting

Study Contacts

- -

Condition/Disease

-

Objectives

-

Test Drug

-

Active Ingredient

-

Dosage Form

-

Dosage

-

Endpoints

-

Inclution Criteria

-

Exclusion Criteria

-

The Estimated Number of Participants

  • Taiwan

    60 participants

  • Global

    632 participants